Medical Treatment in Endometriosis
Common endometriosis medications suppress ovulation and have teratogenic effects, but may preserve fertility by reducing disease activity and preventing new implants, though other methods are ultimately needed for pregnancy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (53)
- A Feasibility Study Exploring the Role of Chinese Herbal Medicine in the Treatment of Endometriosis via openalex
- Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis via openalex
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Chinese herbal medicine for endometriosis via openalex
- [Clinical observation on acupuncture combined with acupoint sticking therapy for treatment of dysmenorrhea caused by endometriosis]. via openalex
- Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis via openalex
- Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model via openalex
- Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex
- [Effect of abdominal acupuncture on pain of pelvic cavity in patients with endometriosis]. via openalex
- Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model via openalex
- Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex
- Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model via openalex
- Endometriosis - Basic Concepts and Current Research Trends via openalex
- Evaluation of Serum ProlactinLevels in Patients with Endometriosisand Infertility via openalex
- Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist via openalex
- Inhibitory and stimulatory actions of danazol in rat ovarian and uterine tissues via openalex
- Is acupuncture in addition to conventional medicine effective as pain treatment for endometriosis? via openalex
- Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Low-dose Oral Contraceptive Pill for Dysmenorrhea Associated with Endometriosis: A Placebo-controlled, Double-blind, Randomized Trial via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol via openalex
- Modern combined oral contraceptives for pain associated with endometriosis via openalex
- Modern combined oral contraceptives for pain associated with endometriosis. via openalex
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex
- Prolactin and cortisol levels in women with endometriosis via openalex
- Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. via openalex
- Reduction of bone mineral density by gonadotropin‐releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
- Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex
- Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The Role of Prolactin– and Endometriosis-Associated Infertility via openalex
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
- Use of GnRH antagonists in the treatment of endometriosis via openalex
- W2079593503 via openalex
- W293131995 via openalex
- W2019198121 via openalex
- W2116798552 via openalex
- W2157853773 via openalex
- W2162917838 via openalex
- W2163624722 via openalex
- W2006703052 via openalex
- W1978196069 via openalex
- W1976256317 via openalex
- W4250773389 via openalex
- W4292208122 via openalex
- W6605975336 via openalex
- W6651446438 via openalex
Cited by (4)
Source provenance
- openalex
- last seen: 2026-06-10T16:23:13.998983+00:00